Navstel
Generic Name: balanced salt ophthalmic solution with hypromellose, dextrose and glutathione
Date of Approval: July 24, 2008
Company: Alcon Laboratories, Inc.
Treatment for: Intraocular Irrigation
FDA Approves Navstel
 |
The United States Food and Drug Administration (FDA) has approved Navstel (balanced salt ophthalmic solution with hypromellose, dextrose and glutathione) for use as an intraocular irrigating solution during surgical procedures involving perfusion of the eye.
Dosage and Administration
The solution should be used according to the standard technique employed by the operating surgeon.
Dosage Forms and Strengths
- 250 mL: 250 mL bottle filled with 240 mL Part I and 10 mL vial filled with 10 mL Part II of sterile intraocular irrigating solution
- 500 mL: 500 mL bottle filled with 480 mL Part I and 20 mL vial filled with 20 mL Part II of sterile intraocular irrigating solution
Contraindications
None
Warnings and Precautions
Do not use this container for more than one patient since Navstel Solution does not contain a preservative.
Adverse Reactions
The most frequently reported adverse reaction in patients exposed to Navstel Solution was increased intraocular pressure, occurring in 12% of patients.
To report SUSPECTED ADVERSE REACTIONS, contact Alcon Laboratories, Inc. at 1-800-757-9195 or FDA at 1800-FDA-1088 or www.fda.gov/medwatch.
Navstel Patient Counseling Information
Patients should be advised to seek immediate care from an ophthalmologist if the eye becomes red, sensitive to light, pain increases or a decrease in vision develops in the days following Navstel Solution administration.
For more information, please see Navstel Product Label. (PDF)
 |
Link to Page |  |
Print Page |  |
Email Page |  | Add to List |
